Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Budget missteps can erode savings fast. This introduction highlights key mistakes and simple fixes to safeguard your funds.
27,863 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Two specialty retailers sit on opposite ends of the consumer tech spectrum. By unpacking their revenue trends, invest...
Forward Air’s path to 2025 earnings rests on freight demand, margins, and disciplined cost management. This guide bre...
A Wall Street titan is backing Crypto.com with a substantial investment, signaling a new era of cross-market liquidit...
Novo Nordisk stock faced renewed selling pressure this week as investors weighed trial results and government-driven ...
When a member of the texas capital bancshares board makes a sizable purchase, it often prompts questions from investo...
A levered crude oil ETF aims for twice the daily move of WTI, but daily resets can magnify losses just as they amplif...
Can Netflix grow from its current scale to a trillion-dollar market value? This article breaks down the unlikely path...
Geopolitics can shake travel stocks fast. This article breaks down how Carnival, the world’s largest cruise operator,...
Take a practical tour of arcutis (arqt) 2026 earnings, from revenue mix and margins to pipeline progress and risk fac...
As Progyny gears up for 2026, investors want clarity on what drives progyny (pgny) 2026 earnings. This guide breaks d...
As brookfield corp's next earnings approaches, investors weigh how the company will navigate its diverse asset mix. T...